Proposed
Bill · 119th Congress · HR 7902
Safeguarding Women from Chemical Abortion Act
Refreshed 2 h ago
Introduced 2026-03-12Topic: health care · public health · criminal justiceSummary
AI-generated summary, report an errorThis bill would treat the federal approval of the drug mifepristone for ending a pregnancy, and approvals of generic versions, as withdrawn 14 days after the bill becomes law. After that, shipping the drug across state lines for this use would violate federal drug law, and the drug would be considered misbranded if its label says it may be used to end a pregnancy. The bill would also make manufacturers of mifepristone liable to people who suffer physical or mental health harm linked in whole or in part to using the drug. Those people could sue in federal or state court for compensatory damages, punitive damages, and attorney's fees, starting 90 days after the bill becomes law.
Sponsors
- Diana Harshbarger Republican sponsor
- 11 cosponsors
Action history
| Date | Chamber | Action | Status effect |
|---|---|---|---|
| 2026-03-12 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. | refer |
| 2026-03-12 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. | refer |
| 2026-03-12 | Introduced in House | introduce | |
| 2026-03-12 | Introduced in House | introduce |